Literature DB >> 8234392

Adenosine receptors and their modulators.

C E Müller1, T Scior.   

Abstract

The identification and characterization of adenosine receptors and the development of potent, receptor subtype-selective agonists and antagonists has been an active area of research for the past 20 years. Major recent advances in the field have been the cloning of several adenosine receptor subtypes of different species, including the discovery of a new subtype, designated A3, the discovery and development of new agonists and antagonists, particularly those with selectivity for the A2a adenosine receptor, the characterization of signal transduction pathways, and the development of agents which act indirectly on the adenosine receptor system. The present article focusses on aspects of pharmaceutical/medicinal chemistry related to adenosine receptors.

Mesh:

Substances:

Year:  1993        PMID: 8234392     DOI: 10.1016/0031-6865(93)90012-u

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  16 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 2.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

3.  Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.

Authors:  Mohamad Wessam Alnouri; Stephan Jepards; Alessandro Casari; Anke C Schiedel; Sonja Hinz; Christa E Müller
Journal:  Purinergic Signal       Date:  2015-07-01       Impact factor: 3.765

4.  Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.

Authors:  Anna Junker; Christian Renn; Clemens Dobelmann; Vigneshwaran Namasivayam; Shanu Jain; Karolina Losenkova; Heikki Irjala; Sierra Duca; Ramachandran Balasubramanian; Saibal Chakraborty; Frederik Börgel; Herbert Zimmermann; Gennady G Yegutkin; Christa E Müller; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

Review 5.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

6.  Effects of adenosine on the functions of circulating polymorphonuclear leukocytes during hyperdynamic endotoxemia.

Authors:  M Thiel; K Holzer; U Kreimeier; S Moritz; K Peter; K Messmer
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Role of extracellular cysteine residues in the adenosine A2A receptor.

Authors:  Elisabetta De Filippo; Vigneshwaran Namasivayam; Lukas Zappe; Ali El-Tayeb; Anke C Schiedel; Christa E Müller
Journal:  Purinergic Signal       Date:  2016-03-11       Impact factor: 3.765

8.  Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PI3-kinase and ERK1/2 pathways.

Authors:  Aftab Ahmad; Jerome B Schaack; Carl W White; Shama Ahmad
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

9.  Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry.

Authors:  E M van der Wenden; S L Price; R P Apaya; A P IJzerman; W Soudijn
Journal:  J Comput Aided Mol Des       Date:  1995-02       Impact factor: 3.686

10.  Experimental hypothyroidism modifies specific binding of A1 and A2A analogues to adenosine receptors in the rat kidney.

Authors:  Martha Franco; Othir Galicia; Alicia Quintana; Flavio Martínez
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.